Dr. Jeff Heddles and EB Research Partnership Unite for a $1 Million Initiative to Boost EB Research Efforts

A Meaningful Match: Accelerating Research for Epidermolysis Bullosa

The fight against Epidermolysis Bullosa (EB), a painful genetic disorder affecting the skin, has recently gained significant traction thanks to a new initiative from the EB Research Partnership (EBRP) and philanthropist Dr. Jeff Heddles. Announced recently, the Matter of Time $1 Million Match is set to double every donation made to EBRP, enhancing momentum in the ongoing battle against this debilitating disease.

EB is rare, affecting around 400 million individuals worldwide, and is characterized by fragile skin that blisters and tears with minimal friction, resembling the delicate wings of a butterfly. Despite this, only about 5% of rare diseases have received FDA-approved treatments. Fortunately, EB is among that small group, with three or more treatments now available—a testament to what can be achieved when research is pursued with diligence and urgency.

The Catalyst for Change

This substantial matching gift was revealed during EBRP's Behind the Film: Matter of Time town hall event, coinciding with the Netflix release of the documentary detailing the struggles and stories surrounding EB. Dr. Heddles became aware of the disease after witnessing a young boy, affected by EB and performing with a tambourine at a Pearl Jam concert, which ignited his commitment to the cause.

“I realized that progress occurs when we collectively refuse to look away from the struggles faced by those living with EB,” said Dr. Heddles. He underscored his aim to transform fleeting awareness into sustained momentum, providing families with the tangible hope of advancements in research and treatment.

The Matter of Time documentary has not only raised awareness about EB but has also encouraged people globally to contribute to EBRP's vital fundraising efforts. The match aims to convert expressions of sympathy into actionable support, appealing to viewers and the broader community.

Momentum Through Generosity

Dr. Heddles has been a pivotal figure in the world of EB philanthropy since 2022. His extensive commitment includes spearheading multiple matching campaigns designed to propel research advances further. The recent match is particularly significant, establishing a high benchmark for philanthropic contributions dedicated to EB research.

Nathan Burmeister, an EBRP board member and father to a child with Recessive Dystrophic Epidermolysis Bullosa (RDEB), expressed heartfelt gratitude toward Dr. Heddles, stating, “His generosity will help bring us closer to effective treatments and, ultimately, a cure.” His remarks reflect a community deeply appreciative of any advancements made possible through such philanthropic efforts.

Driving the Research Forward

The Matter of Time $1 Million Match is strategically aligned with EBRP's goal of accelerating ongoing research initiatives. Starting from February 26, 2026, all contributions to EBRP will be matched dollar for dollar until the million-dollar target is reached. This innovative philanthropic model not only allows EBRP to fund significant research but also embodies a collective drive to enhance the clinical landscape of EB dramatically.

Michael Hund, CEO of EBRP, emphasized the transformative nature of Dr. Heddles’ leadership. He proclaimed, “This matching contribution serves as an invitation to the world. If you resonate with the powerful narratives in Matter of Time, this is the moment to facilitate action.”

EBRP has achieved notable milestones since its inception in 2010. With the aid of innovative funding strategies, it has accelerated three FDA-approved treatments and initiated over 50 active clinical trials dedicated to EB worldwide.

The Bigger Picture

The growing public attention towards EB, heightened by the Matter of Time documentary, has amplified the imperative need for continued fundraising. The global audience now has an opportunity to engage more deeply with the reality of living with EB and contribute to the advancements in treatment options.

By harnessing this moment of awareness, EBRP aims to transform public sentiment into meaningful progress in research and clinical endeavors. Individuals looking to make a difference can proceed to donate at ebresearch.org, as each dollar now holds the power to be matched, aiding in a future where EB patients can lead fuller lives.

In conclusion, Dr. Heddles' matching campaign marks a pivotal chapter in the quest for medical breakthroughs in EB treatment—an inspiring reminder of how communal effort and philanthropy can catalyze significant change in healthcare and patient care for rare diseases.